{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T12:18:46Z","timestamp":1789647526188,"version":"4.0.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.diagmicrobio.2020.115016","type":"journal-article","created":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T20:14:55Z","timestamp":1581538495000},"page":"115016","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Bacterial and fungal pathogens isolated from patients with bloodstream infection: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (2012\u20132017)"],"prefix":"10.1016","volume":"97","author":[{"given":"Michael A.","family":"Pfaller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia G.","family":"Carvalhaes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin J.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Diekema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Castanheira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2020.115016_bb0005","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.diagmicrobio.2010.10.026","article-title":"Prevalence of antimicrobial resistant pathogens from blood cultures from Canadian hospitals: results of the CANWARD 2007-2009 study","volume":"69","author":"Adam","year":"2011","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2020.115016_bb0010","doi-asserted-by":"crossref","unstructured":"Ammerlaan, H.S., Harbarth, S., Buiting, A.G., Crook, D.W., Fitzpatrick, F., Hanberger, H., Herwaldt, L.A., van Keulen, P.H., Kluytmans, J.A., Kola, A., Kuchenbecker, R.S., Lingaas, E., Meessen, N., Morris-Downes, M.M., Pottinger, J.M., Rohner, P., dos Santos, R.P., Seifert, H., Wisplinghoff, H., Ziesing, S., Walker, A.S., & Bonten, M.J. (2013) Secular trends in nosocomial bloodstream infections: antibiotic-resistant bacteria increase the total burden of infection. Clin Infect Dis, 56: 798\u2013805.","DOI":"10.1093\/cid\/cis1006"},{"key":"10.1016\/j.diagmicrobio.2020.115016_bb0015","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.diagmicrobio.2004.05.003","article-title":"Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997\u20132002)","volume":"50","author":"Biedenbach","year":"2004","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2020.115016_bb0020","doi-asserted-by":"crossref","unstructured":"Caliendo, A.M., Gilbert, D.N., Ginocchio, C.C., Hanson, K.E., May, L., Quinn, T.C., Tenover, F.C., Alland, D., Blaschke, A.J., Bonomo, R.A., Carroll, K.C., Ferraro, M.J., Hirschhorn, L.R., Joseph, W.P., Karchmer, T., MacIntyre, A.T., Reller, L.B., Jackson, A.F., & Infectious Diseases Society of, A. (2013) Better tests, better care: improved diagnostics for infectious diseases. Clin Infect Dis, 57 Suppl 3: S139\u2013170.","DOI":"10.1093\/cid\/cit578"},{"key":"10.1016\/j.diagmicrobio.2020.115016_bb0025","first-page":"205","article-title":"Improved understanding of factors driving methicillin-resistant Staphylococcus aureus epidemic waves","volume":"5","author":"Chatterjee","year":"2013","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.diagmicrobio.2020.115016_bb0030","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1017\/ice.2016.254","article-title":"Incidence and outcomes associated with infections caused by vancomycin-resistant enterococci in the United States: systematic literature review and meta-analysis","volume":"38","author":"Chiang","year":"2017","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.diagmicrobio.2020.115016_bb0035","series-title":"M27Ed4E. Reference method for broth dilution antifungal susceptibility testing of yeasts","author":"CLSI","year":"2017"},{"key":"10.1016\/j.diagmicrobio.2020.115016_bb0040","series-title":"M60Ed1E. Performance standards for antifungal susceptibility testing of yeasts","author":"CLSI","year":"2017"},{"key":"10.1016\/j.diagmicrobio.2020.115016_bb0045","series-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard: eleventh edition","article-title":"M07Ed11","author":"CLSI","year":"2018"},{"key":"10.1016\/j.diagmicrobio.2020.115016_bb0050","unstructured":"CLSI. 2019. M100Ed29. Performance standards for antimicrobial susceptibility testing: 29th informational supplement. Clinical and Laboratory Standards Institute, Wayne, PA."},{"key":"10.1016\/j.diagmicrobio.2020.115016_bb0055","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1086\/499406","article-title":"The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs","volume":"42","author":"Cosgrove","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2020.115016_bb0060","doi-asserted-by":"crossref","unstructured":"Dellinger, R.P., Levy, M.M., Rhodes, A., Annane, D., Gerlach, H., Opal, S.M., Sevransky, J.E., Sprung, C.L., Douglas, I.S., Jaeschke, R., Osborn, T.M., Nunnally, M.E., Townsend, S.R., Reinhart, K., Kleinpell, R.M., Angus, D.C., Deutschman, C.S., Machado, F.R., Rubenfeld, G.D., Webb, S.A., Beale, R.J., Vincent, J.L., Moreno, R., & Surviving Sepsis Campaign Guidelines Committee including the Pediatric, S. (2013) Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med, 41: 580\u2013637.","DOI":"10.1097\/CCM.0b013e31827e83af"},{"key":"10.1016\/j.diagmicrobio.2020.115016_bb0065","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.diagmicrobio.2006.12.022","article-title":"Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: a report from the SENTRY Antimicrobial Surveillance Program","volume":"58","author":"Deshpande","year":"2007","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2020.115016_bb0070","doi-asserted-by":"crossref","first-page":"6256","DOI":"10.1128\/AAC.01473-15","article-title":"Detection of a new cfr-like gene, cfr(B), in Enterococcus faecium recovered from human specimens in the United States: report from the SENTRY Antimicrobial Surveillance Program","volume":"59","author":"Deshpande","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2020.115016_bb0075","doi-asserted-by":"crossref","unstructured":"Diekema, D.J., Pfaller, M.A., Jones, R.N., & Group, S.P. (2002) Age-related trends in pathogen frequency and antimicrobial susceptibility of bloodstream isolates in North America: SENTRY Antimicrobial Surveillance Program, 1997\u20132000. Int J Antimicrob Agents, 20: 412\u2013418.","DOI":"10.1016\/S0924-8579(02)00204-2"},{"key":"10.1016\/j.diagmicrobio.2020.115016_bb0080","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1086\/520192","article-title":"Nosocomial bloodstream infections in United States hospitals: a three-year analysis","volume":"29","author":"Edmond","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2020.115016_bb0085","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ijantimicag.2009.07.006","article-title":"Impact of early appropriate antimicrobial therapy on survival in Acinetobacter baumannii bloodstream infections","volume":"34","author":"Erbay","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.diagmicrobio.2020.115016_bb0090","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1126\/science.aap7999","article-title":"Worldwide emergence of resistance to antifungal drugs challenges human health and food security","volume":"360","author":"Fisher","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.diagmicrobio.2020.115016_bb0095","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1093\/ofid\/ofy346","article-title":"The importance of antimicrobial resistance monitoring worldwide and the origins of SENTRY Antimicrobial Surveillance Program","volume":"6","author":"Fuhrmeister","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2020.115016_bb0100","doi-asserted-by":"crossref","first-page":"19819","DOI":"10.2807\/ese.16.11.19819-en","article-title":"Escherichia coli and Staphylococcus aureus: bad news and good news from the European Antimicrobial Resistance Surveillance Network (EARS-Net, formerly EARSS), 2002 to 2009","volume":"16","author":"Gagliotti","year":"2011","journal-title":"Euro Surveill"},{"key":"10.1016\/j.diagmicrobio.2020.115016_bb0105","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/1469-0691.12195","article-title":"Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe","volume":"19","author":"Goto","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.diagmicrobio.2020.115016_bb0110","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1378\/chest.118.1.146","article-title":"The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting","volume":"118","author":"Ibrahim","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.diagmicrobio.2020.115016_bb0115","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.1128\/JCM.41.8.4004-4005.2003","article-title":"Distribution of fsr among Enterococcus faecalis isolates from the SENTRY antimicrobial surveillance program","volume":"41","author":"Jones","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2020.115016_bb0120","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1128\/AAC.49.2.760-766.2005","article-title":"Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome","volume":"49","author":"Kang","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2020.115016_bb0125","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1378\/chest.115.2.462","article-title":"Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients","volume":"115","author":"Kollef","year":"1999","journal-title":"Chest"},{"key":"10.1016\/j.diagmicrobio.2020.115016_bb0130","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3389\/fmicb.2016.00697","article-title":"How to optimize the use of blood cultures for the diagnosis of bloodstream infections? A state-of-the art","volume":"7","author":"Lamy","year":"2016","journal-title":"Front Microbiol"},{"key":"10.1016\/j.diagmicrobio.2020.115016_bb0135","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.3201\/eid2109.141333","article-title":"Twenty years of active bacterial core surveillance","volume":"21","author":"Langley","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2020.115016_bb0140","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1007\/s10096-011-1257-3","article-title":"Species-driven interpretation guidelines in case of a single-sampling strategy for blood culture","volume":"30","author":"Leyssene","year":"2011","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2020.115016_bb0145","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1086\/375057","article-title":"Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia","volume":"36","author":"Lodise","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2020.115016_bb0150","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.1086\/320185","article-title":"Clinical prevalence, antimicrobial susceptibility, and geographic resistance patterns of enterococci: results from the SENTRY Antimicrobial surveillance Program, 1997-1999","volume":"32","author":"Low","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2020.115016_bb0155","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1378\/chest.111.3.676","article-title":"Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia","volume":"111","author":"Luna","year":"1997","journal-title":"Chest"},{"key":"10.1016\/j.diagmicrobio.2020.115016_bb0160","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.diagmicrobio.2010.10.016","article-title":"Prevalence and epidemiology of microbial pathogens causing bloodstream infections: results of the OASIS multicenter study","volume":"69","author":"Luzzaro","year":"2011","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2020.115016_bb0165","doi-asserted-by":"crossref","unstructured":"Magill, S.S., O'Leary, E., Janelle, S.J., Thompson, D.L., Dumyati, G., Nadle, J., Wilson, L.E., Kainer, M.A., Lynfield, R., Greissman, S., Ray, S.M., Beldavs, Z., Gross, C., Bamberg, W., Sievers, M., Concannon, C., Buhr, N., Warnke, L., Maloney, M., Ocampo, V., Brooks, J., Oyewumi, T., Sharmin, S., Richards, K., Rainbow, J., Samper, M., Hancock, E.B., Leaptrot, D., Scalise, E., Badrun, F., Phelps, R., Edwards, J.R., & Emerging Infections Program Hospital Prevalence Survey, T. (2018) Changes in prevalence of health care-associated infections in U.S. hospitals. N Engl J Med, 379: 1732\u20131744.","DOI":"10.1056\/NEJMoa1801550"},{"key":"10.1016\/j.diagmicrobio.2020.115016_bb0170","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.diagmicrobio.2020.115016_bb0175","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1017\/ice.2017.156","article-title":"Incidence of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella infections in the United States: a systematic literature review","volume":"38","author":"McDanel","year":"2017","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.diagmicrobio.2020.115016_bb0180","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1093\/jac\/dkw319","article-title":"Longitudinal (2001\u201314) analysis of enterococci and VRE causing invasive infections in European and US hospitals, including a contemporary (2010\u201313) analysis of oritavancin in vitro potency","volume":"71","author":"Mendes","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2020.115016_bb0185","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1128\/AAC.49.4.1306-1311.2005","article-title":"Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment","volume":"49","author":"Micek","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2020.115016_bb0190","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1128\/AAC.49.9.3640-3645.2005","article-title":"Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality","volume":"49","author":"Morrell","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2020.115016_bb0195","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0732-8893(03)00012-9","article-title":"Geographic variations and trends in antimicrobial resistance among Enterococcus faecalis and Enterococcus faecium in the SENTRY Antimicrobial Surveillance Program (1997\u20132000)","volume":"46","author":"Mutnick","year":"2003","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2020.115016_bb0200","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cmi.2017.07.014","article-title":"The methodology of surveillance for antimicrobial resistance and healthcare-associated infections in Europe (SUSPIRE): a systematic review of publicly available information","volume":"24","author":"Nunez-Nunez","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.diagmicrobio.2020.115016_bb0205","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1001\/jama.2010.1125","article-title":"Decline in invasive MRSA infection: where to go from here?","volume":"304","author":"Perencevich","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.diagmicrobio.2020.115016_bb0210","first-page":"1","article-title":"Nosocomial candidiasis: antifungal stewardship and the importance of rapid diagnosis","volume":"54","author":"Pfaller","year":"2016","journal-title":"Med Mycol"},{"key":"10.1016\/j.diagmicrobio.2020.115016_bb0215","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0732-8893(98)00149-7","article-title":"Survey of blood stream infections attributable to gram-positive cocci: frequency of occurrence and antimicrobial susceptibility of isolates collected in 1997 in the United States, Canada, and Latin America from the SENTRY Antimicrobial Surveillance Program","volume":"33","author":"Pfaller","year":"1999","journal-title":"SENTRY Participants Group Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2020.115016_bb0220","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.amjmed.2010.03.021","article-title":"The clinical and prognostic importance of positive blood cultures in adults","volume":"123","author":"Pien","year":"2010","journal-title":"Am J Med"},{"key":"10.1016\/j.diagmicrobio.2020.115016_bb0225","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10096-018-3428-y","article-title":"A global priority list of the TOp TEn resistant Microorganisms (TOTEM) study at intensive care: a prioritization exercise based on multi-criteria decision analysis","volume":"38","author":"Rello","year":"2019","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2020.115016_bb0230","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/cid\/cir326","article-title":"Geographic variation in invasive pneumococcal disease following pneumococcal conjugate vaccine introduction in the United States","volume":"53","author":"Rosen","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2020.115016_bb0235","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1093\/ofid\/ofy345","article-title":"Antimicrobial resistance surveillance and new drug development","volume":"6","author":"Sader","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2020.115016_bb0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0121493","article-title":"Survey of physicians' perspectives and knowledge about diagnostic tests for bloodstream infections","volume":"10","author":"She","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.diagmicrobio.2020.115016_bb0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0190132","article-title":"Implementation of global antimicrobial resistance surveillance system (GLASS) in patients with bacteremia","volume":"13","author":"Sirijatuphat","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.diagmicrobio.2020.115016_bb0250","doi-asserted-by":"crossref","first-page":"826","DOI":"10.15585\/mmwr.mm6430a4","article-title":"Vital signs: estimated effects of a coordinated approach for action to reduce antibiotic-resistant infections in health care facilities \u2014 United States","volume":"64","author":"Slayton","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.diagmicrobio.2020.115016_bb0255","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1128\/AAC.01509-06","article-title":"Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase\u2013producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment","volume":"51","author":"Tumbarello","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2020.115016_bb0260","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1086\/657912","article-title":"Estimating the proportion of healthcare-associated infections that are reasonably preventable and the related mortality and costs","volume":"32","author":"Umscheid","year":"2011","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.diagmicrobio.2020.115016_bb0265","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1017\/ice.2016.174","article-title":"Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011\u20132014","volume":"37","author":"Weiner","year":"2016","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"Suppl. 1","key":"10.1016\/j.diagmicrobio.2020.115016_bb0270","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1086\/518136","article-title":"Health care-associated infections: major issues in the early years of the 21st century","volume":"45","author":"Wenzel","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2020.115016_bb0275","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1086\/421946","article-title":"Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study","volume":"39","author":"Wisplinghoff","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2020.115016_bb0280","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1097\/CCM.0000000000001140","article-title":"Time to appropriate antibiotic therapy is an independent determinant of postinfection ICU and hospital lengths of stay in patients with sepsis","volume":"43","author":"Zhang","year":"2015","journal-title":"Crit Care Med"},{"key":"10.1016\/j.diagmicrobio.2020.115016_bb0285","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1097\/CCM.0000000000001219","article-title":"Appropriate antibiotic treatment in severe sepsis and septic shock: timing is everything","volume":"43","author":"Zilberberg","year":"2015","journal-title":"Crit Care Med"},{"key":"10.1016\/j.diagmicrobio.2020.115016_bb0290","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1001\/jamainternmed.2013.9763","article-title":"Health care-associated infections: a meta-analysis of costs and financial impact on the US health care system","volume":"173","author":"Zimlichman","year":"2013","journal-title":"JAMA Intern Med"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889319310934?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889319310934?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:53:55Z","timestamp":1760003635000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889319310934"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S0732889319310934"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2020.115016","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bacterial and fungal pathogens isolated from patients with bloodstream infection: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (2012\u20132017)","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2020.115016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115016"}}